Godavari Biorefineries Live Share Price Today, Share Analysis and Chart

About the company - Business Profile

Godavari Biorefineries Ltd. is an integrated biorefinery and a global manufacturer of bio-based chemicals, sugar, rectified spirit, ethanol, and power. The company utilizes sugarcane as its primary feedstock to produce a diversified portfolio of products catering to industries such as food, beverages, pharmaceuticals, cosmetics, and chemicals. By integrating sugar production with downstream value-added chemicals and biofuels, the company maximizes the utilization of biomass through a circular economy model.

Key Points

• Key Facts:
  • Founded: The company has a legacy spanning several decades, originating from the Somaiya Group.
  • Headquarters: Mumbai, Maharashtra.
  • Stock Listing: Listed on BSE and NSE (Stock Code: GODAVARIB).
  • Key Brands: Jivana (Consumer products including sugar and salt).
• Operations and Resources:
  • The company operates two main manufacturing facilities located in Sameerwadi (Karnataka) and Sakarwadi (Maharashtra).
  • It maintains three DSIR-registered R&D facilities focused on new product development and process efficiency.
  • The R&D team comprises over 50 researchers and scientists.
• Market and Significance:
  • GBL serves diverse industries including personal care, cosmetics, food, fragrance, fuel, paints, agrochemicals, mining, and pharmaceuticals.
  • It holds a strategic position in India's green energy transition through ethanol blending and the development of bio-based specialty chemicals that replace fossil-based alternatives.
• Business Model and Strengths:
  • Integrated Biorefinery Model: GBL uses a "whole-crop" approach, where sugarcane is converted into sugar, the molasses into ethanol, and the fiber (bagasse) into power.
  • Co-creation Model: The company collaborates with customers to develop specific green chemicals, providing sustainable substitutes with lower carbon footprints.
  • Product Excellence: GBL is a leader in specialty bio-based chemicals like MPO (3-Methyl-3-penten-2-one) and other derivatives used in global fragrance and flavor industries.
• Revenue Breakdown (FY2025):
  • Total Revenue: ₹1,32,803.51 Lakhs (Consolidated).
  • Sugar Segment: ₹1,31,296.70 Lakhs.
  • Bio-based Chemicals: ₹43,063.02 Lakhs (reported for nine months ending Dec 2025).
  • Distillery (Ethanol): ₹59,399.89 Lakhs.
  • Cogeneration: ₹16,248.22 Lakhs.
  • Note: Revenue figures include inter-segment transfers of ₹(76,162.94) Lakhs.
• Key Products and Technology Advancements:
  • Bio-based Specialty Chemicals: Focus on producing green drop-in substitutes for fossil-fuel-based chemicals.
  • DME Technology: Launched a pilot project with ICT Mumbai for CO2-to-DME (Dimethyl Ether) technology, targeting carbon capture and climate action.
  • Drug Discovery: Developing novel anti-cancer molecules through its subsidiary; clinical study reports for safety trials have been received.
  • Ethanol Expansion: Progressing with a 200 KLPD fungible Grain/Maize distillery expected to be operational by Q4 FY26, adding 60 million liters of capacity per annum.
• Strategic Initiatives and Future Outlook:
  • Diversification of Feedstock: Transitioning from sugar-only feedstock to grain and maize for ethanol production to ensure year-round operations.
  • Subsidiary Expansion: Incorporated Sathgen Therapeutics LLC in the United States to market cancer drug IP and pursue licensing.
  • Consumer Brand Growth: The Jivana brand achieved revenue of ₹108 Crores in FY25, with a 3-year CAGR of 56%.
  • Sustainability Goals: Committed to a "Triple Bottom Line" approach focusing on social, environmental, and financial growth, with a roadmap for carbon neutrality.

References

1. Annual Report May 2025
2. Result Feb 2026
3. Investor Presentation Feb 2026
4. Earnings Call Nov 2025
5. Investor Presentation Nov 2025